Print this page
 Email this page

 Connect with UMMC on:
 Twitter
 Facebook
 YouTube
iPhone

 Share this page:

Bookmark and Share

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

 

Video details

[ Flash player icon ] Please install flash player to see this video.

Hospital Virtual Tour

Click to take a virtual tour

Related Content


 

Vitiligo - Treatment

Treatment:

Vitiligo is difficult to treat. Early treatment options include the following:

  • Light therapy (exposure to controlled intense ultraviolet light in a doctor's office or hospital)
  • Medicines taken by mouth such as trimethylpsoralen (Trisoralen)
  • Medicines applied to the skin such as:
    • Corticosteroid creams
    • Immunosuppressants such as pimecrolimus (Elidel) and tacrolimus (Protopic)
    • Repigmenting agents such as methoxsalen (Oxsoralen)

Skin may be grafted or removed from normal areas and placed onto areas of pigment loss.

Several manufacturers produce cover-up makeup or skin dyes to mask vitiligo. Ask your health care provider for the names of these companies.

In extreme cases when most of the body is affected, the remaining pigmented skin may be de-pigmented. This is a permanent change and is a last resort.

It is important to remember that skin without pigment is extremely susceptible to the sun's damaging effects. Be sure to apply a high-SPF sunblock and use appropriate safeguards against sun exposure.

Support Groups:

  • American Vitiligo Research Foundation -- www.avrf.org
  • National Vitiligo Foundation -- www.nvfi.org
  • VitiligoSupport.com -- www.vitiligosupport.org

Expectations (prognosis):

The course of vitiligo varies. Some areas may regain pigmentation (coloring), but other new areas may appear. Loss of pigment may be progressive.

Complications:

Depigmented areas are more likely to sunburn or develop certain skin cancers.

Calling your health care provider:

Call for an appointment with your health care provider if you develop areas of skin that lose their coloring.

  • Reviewed last on: 7/11/2008
  • Michael Lehrer, M.D., Department of Dermatology, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com